Pulmonary Lymphangioleiomyomatosis: Correlation of Ventilation-Perfusion Scintigraphy, Chest Radiography, and CT with Pulmonary Function Tests
Abstract
PURPOSE: To determine the findings on ventilation-perfusion (V-P) scintigrams, computed tomographic (CT) scans, and chest radiographs and correlate them with pulmonary function test results in patients with lymphangioleiomyomatosis.
MATERIALS AND METHODS: V-P scintigraphy, chest radiography, conventional and thin-section CT, and pulmonary function tests were performed in 39 patients. The images were graded on a scale of 0 (normal) to 3 (severely abnormal).
RESULTS: Imaging abnormalities were found on 92% of ventilation scintigrams, 92% of perfusion scintigrams, 79% of chest radiographs, 100% of CT scans, and 100% of thin-section CT scans. On ventilation scintigrams, 28 (72%) patients demonstrated a speckling pattern. On CT scans, all patients had pulmonary cysts. Univariate analysis showed that extent of disease on chest radiographs and CT scans, cyst size, V-P abnormalities, and degree of speckling were inversely correlated with forced expiratory volume in one second (FEV1), diffusing capacity of lung for carbon monoxide, and the ratio of FEV1 to forced vital capacity (FVC) (P < .01) but not with FVC and total lung capacity. Larger cyst size correlated with extent of disease at CT, but not significantly (P = .056).
CONCLUSION: Scintigraphic and radiologic abnormalities are seen in a majority of patients with lymphangioleiomyomatosis. On ventilation scintigrams, a frequently seen speckling pattern may be related to accumulation of radionuclide in pulmonary cysts—a hallmark of the disease at CT. Findings with each imaging modality correlate with certain pulmonary functions.
References
- 1 Corrin B, Liebow AA, Friedman PJ. Pulmonary lymphangiomyomatosis: a review. Am J Pathol 1975; 79:348-367.
- 2 Carrington CB, Cugell DW, Gaensler EA, et al. Lymphangiomyomatosis: physiologic-pathologic-radiologic correlations. Am Rev Respir Dis 1977; 116:977-995.
- 3 Berger JL, Shaff MI. Pulmonary lymphangioleiomyomatosis. J Comput Assist Tomogr 1981; 5:565-567.
- 4 Merchant RN, Pearson MG, Rankin RN, Morgan WKC. Computerized tomography in the diagnosis of lymphangioleiomyomatosis. Am Rev Respir Dis 1985; 131:295-297.
- 5 Templeton PA, McLoud TC, Muller NL, Shepard JO, Moore EH. Pulmonary lymphangioleiomyomatosis: CT and pathologic findings. J Comput Assist Tomogr 1989; 13:54-57.
- 6 Rappaport DC, Weisbrod GL, Herman SJ, Chamberlain DW. Pulmonary lymphangioleiomyomatosis: high-resolution CT findings in four cases. AJR Am J Roentgenol 1989; 152:961-964.
- 7 Sherrier RH, Chiles C, Roggli V. Pulmonary lymphangioleiomyomatosis: CT findings. AJR Am J Roentgenol 1989; 153:937-940.
- 8 Müller NL, Chiles C, Kullnig P. Pulmonary lymphangiomyomatosis: correlation of CT with radiographic and functional findings. Radiology 1990; 175:335-339.
- 9 Aberle DR, Hansell DM, Brown K, Tashkin DP. Lymphangiomyomatosis: CT, chest radiographic, and functional correlations. Radiology 1990; 176:381-387.
- 10 Fanti S, Monetti N, Schiavina M, Rimondi MR. Scintigraphic findings in a case of lymphangioleiomyomatosis. Clin Nucl Med 1995; 20:1034-1035.
- 11 American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:1107-1136.
- 12 American Thoracic Society. Single breath carbon monoxide diffusing capacity (transfer factor): recommendations for a standard technique—1995 update. Am J Respir Crit Care Med 1995; 152:2185-2198.
- 13 Morris JF, Koski A, Johnson LC. Spirometric standards for healthy nonsmoking adults. Am Rev Respir Dis 1971; 103:57-67.
- 14 Goldman HI, Becklake MR. Respiratory function tests: normal values at median altitudes and the prediction of normal results. Am Rev Tuberc Pulm Dis 1959; 79:457-467.
- 15 Gaensler EA, Wright GW. Evaluation of respiratory impairment. Arch Environ Health 1966; 12:146-189.
- 16 Fleiss JL. Statistical methods for rates and proportions 2nd ed. New York, NY: Wiley, 1981.
- 17 Snedecor GW, Cochran WG. Statistical methods Ames, Iowa: The Iowa State College Press, 1957.
- 18 SAS user's guide: basics 1982 ed Cary, NC: SAS Institute, 1982.
- 19 Braman SS, Mark EJ, McCloud TC, Levine BW. A 32-year-old woman with recurrent pneumothorax: pulmonary lymphangiomyomatosis. N Engl J Med 1988; 318:1601-1610.
- 20 Hayashi T, Fleming MV, Stetler-Stevenson WG, et al. Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM). Hum Pathol 1997; 28:1071-1078.
- 21 Lenoir S, Grenier P, Brauner MW, et al. Pulmonary lymphangiomyomatosis and tuberous sclerosis: comparison of radiographic and thin-section CT findings. Radiology 1990; 175:329-334.
- 22 Hruban RH, Meziane MA, Zerhouni EA, et al. High resolution computed tomography of inflation-fixed lungs: pathologic-radiologic correlation of centrilobular emphysema. Am Rev Respir Dis 1987; 136:935-940.
- 23 Murata K, Itoh H, Todo G, et al. Centrilobular lesions of the lung: demonstration by high-resolution CT and pathologic correlation. Radiology 1986; 161:641-645.
- 24 Kuni CC, Regelmann WE, duCret PR, et al. Aerosol scintigraphy in the assessment of therapy for cystic fibrosis. Clin Nucl Med 1992; 17:90-93.
- 25 Moore ADA, Godwin JD, Muller NL, et al. Pulmonary histiocytosis X: comparison of radiographic and CT findings. Radiology 1989; 172:249-254.
- 26 Brauner MW, Grenier P, Mouelhi MM, Mompoint D, Lenoir S. Pulmonary histiocytosis X: evaluation with high-resolution CT. Radiology 1989; 172:255-258.
